Please use this identifier to cite or link to this item:
Title: Therapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs
Authors: Vilar, Jose M. 
Damiá, E.
Rubió, M.
Santana, Angelo 
Sopena, J.
Cerón Madrigal, José Joaquín
Tvarijonaviciute, Asta
Cugat, R.
Carrillo, J.M.
UNESCO Clasification: 3109 Ciencias veterinarias
120903 Análisis de datos
240401 Bioestadística
Keywords: Plasma rich in growth factors
Insulin-like growth factor 1
C-reactive protein
CRP, et al
Issue Date: 2017
Journal: Journal of Applied Animal Research 
Abstract: A potential relationship between an increased risk of cancer and increased levels of serum insulin-like growth factor-1 (IGF-1), and presence of cancer and high levels of C-reactive protein (CRP) has been previously reported. This study evaluated the influence of a single intramuscular injection of plasma rich in growth factors (PRGF) on serum concentrations of IGF-1 and CRP in dogs. Two groups of eight healthy beagles were injected with two different doses of PRGF in lumbar muscles. For each treatment, IGF-1 and CRP were analysed from blood samples obtained at baseline and the following three days post injection. No differences were found when IGF-1 and CRP were compared among times in the two protocols. Local application of PRGF at clinical doses did not cause significant changes in systemic concentrations of IGF-1 or detectable inflammation.
ISSN: 0971-2119
DOI: 10.1080/09712119.2016.1218888
Source: Journal of Applied Animal Research[ISSN 0971-2119],v. 45, p. 490-493
Appears in Collections:Artículos
Show full item record


checked on May 2, 2021

Page view(s)

checked on May 3, 2021

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.